Pseudotype-based neutralization assays for influenza: a systematic analysis
The use of vaccination against the influenza virus remains the most effective method of mitigating the significant morbidity and mortality caused by this virus. Antibodies elicited by currently licensed influenza vaccines are predominantly hemagglutination-inhibition (HI)-competent antibodies that...
Main Authors: | George William Carnell, Francesca eFerrara, Keith eGrehan, Craig Peter Thompson, Nigel James Temperton |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-04-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00161/full |
Similar Items
-
Development of Lentiviral Vectors Pseudotyped With Influenza B Hemagglutinins: Application in Vaccine Immunogenicity, mAb Potency, and Sero-Surveillance Studies
by: Francesca Ferrara, et al.
Published: (2021-05-01) -
Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
by: Francesca Ferrara, et al.
Published: (2017-01-01) -
An optimised method for the production of MERS-CoV spike expressing viral pseudotypes
by: K. Grehan, et al.
Published: (2015-01-01) -
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
by: Alexis Duvergé, et al.
Published: (2020-11-01) -
Exploiting Pan Influenza A and Pan Influenza B Pseudotype Libraries for Efficient Vaccine Antigen Selection
by: Joanne Marie M. Del Rosario, et al.
Published: (2021-07-01)